10x Genomics Inc (TXG)

10x Genomics (TXG) Financial Statements


10x Genomics Financial Overview

10x Genomics's market cap is currently ―. The company's EPS TTM is $-2.239; its P/E ratio is -7.81; 10x Genomics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.47. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 141.01M$ 183.98M$ 153.64M$ 146.82M$ 134.28M
Gross Profit$ 92.91M$ 115.78M$ 95.53M$ 146.82M$ 98.39M
EBIT$ -57.80M$ -46.59M$ -91.74M$ -60.76M$ -49.63M
EBITDA$ -46.31M$ -34.88M$ -80.32M$ -48.88M$ -41.02M
Net Income Common Stockholders$ -59.95M$ -48.95M$ -10.18M$ -62.41M$ -50.75M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 371.81M$ 388.69M$ 356.91M$ 392.88M$ 420.79M
Total Assets$ 922.91M$ 965.14M$ 948.54M$ 989.64M$ 1.01B
Total Debt$ 92.18M$ 95.37M$ 98.47M$ 99.62M$ 102.04M
Net Debt$ -279.64M$ -293.32M$ -258.43M$ -293.27M$ -318.75M
Total Liabilities$ 204.08M$ 224.10M$ 203.32M$ 196.34M$ 211.65M
Stockholders Equity$ 718.83M$ 741.04M$ 745.22M$ 793.30M$ 802.38M
Cash Flow-
Free Cash Flow$ -18.64M$ 22.31M$ -40.76M$ -36.87M$ -9.41M
Operating Cash Flow$ -15.72M$ 25.76M$ -25.32M$ -11.51M$ -4.13M
Investing Cash Flow$ 10.63M$ 13.10M$ 4.90M$ -4.46M$ 119.96M
Financing Cash Flow$ 1.64M$ 5.61M$ 4.37M$ 7.10M$ -3.41M
Currency in USD

10x Genomics Earnings and Revenue History

10x Genomics Debt to Assets

10x Genomics Cash Flow

10x Genomics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis